Results 1 to 10 of about 36,155 (116)

Clinical Predictors and Risk Factors of Gleason Score Upgrade: A Retrospective Cohort Analysis [PDF]

Diagnostics
Background: In prostate cancer (PCa) patients, discrepancies between biopsy-assigned Gleason Scores and those determined from surgical specimens are frequently reported. This phenomenon, known as Gleason score upgrade (GSU), can have significant clinical
Carmine Sciorio, Riccardo Giannella, Lorenzo Romano, Benito Fabio Mirto, Antonio Di Girolamo, Antonio Ruffo, Giuseppe Romeo, Fabio Esposito, Felice Crocetto, Luigi Napolitano, Raffaele Balsamo, Francesco Trama, Francesco Bottone, Carmelo Quattrone, Vittorio Imperatore, Lorenzo Spirito   +15 more
doaj   +2 more sources

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy [PDF]

Diagnostics, 2021
Background: The impact of MRI-lesion targeted (TB) and systematic biopsy (SB) Gleason score (GS) as a predictor for final pathological GS still remains unclear. Methods: All patients with TB + SB, and subsequent radical prostatectomy (RP) between 01/2014-
Mike Wenzel, Felix Preisser, Clarissa Wittler, Benedikt Hoeh, Peter J. Wild, Alexandra Tschäbunin, Boris Bodelle, Christoph Würnschimmel, Derya Tilki, Markus Graefen, Andreas Becker, Pierre I Karakiewicz, Felix K. H. Chun, Luis A Kluth, Jens Köllermann, Philipp Mandel   +15 more
doaj   +2 more sources

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy

Diagnostics, 2020
Biopsy proven Gleason score is essential to decide treatment modalities for prostate cancer, either surgical (radical prostatectomy) or non-surgical (active surveillance, watchful waiting, radiation therapy and hormone therapy). Several studies indicated
Vincenzo Fiorentino, Maurizio Martini, Marco Dell’Aquila, Teresa Musarra, Ersilia Orticelli, Luigi Maria Larocca, Ernesto Rossi, Angelo Totaro, Francesco Pinto, Niccolò Lenci, Valerio Di Paola, Riccardo Manfredi, Pier Francesco Bassi, Francesco Pierconti   +13 more
doaj   +1 more source

Association of BMI and Age with Gleason Score and PSA in Patients with Prostate Cancer [PDF]

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2023
Background and Objective: Obesity has produced conflicting results on various indices of prostate cancer diagnosis. Since the effect of body mass index (BMI) on Gleason score and prostate specific antigen (PSA) as well as the overall classified risk of ...
SA Mazloumi, E Moudi, H Shafi, H Gholinia   +3 more
doaj  

The highest percentage of Gleason Pattern 4 is a predictor in intermediate‐risk prostate cancer

BJUI Compass, 2023
Objectives This study aims to clarify the clinicopathological significance of several novel pathological markers, including the percentage of Gleason pattern 4 and small/non‐small cribriform pattern, in intermediate‐risk Gleason score 3 + 4 = 7 prostate ...
Shun Sato, Takahiro Kimura, Hajime Onuma, Shin Egawa, Masayuki Shimoda, Hiroyuki Takahashi   +5 more
doaj   +1 more source

Collagen I and III and metalloproteinase gene and protein expression in prostate cancer in relation to Gleason score

International Brazilian Journal of Urology, 2012
PURPOSE: To evaluate if the expression of metalloproteinase, collagen I and III are related to Gleason score, preoperative PSA and pathological stage in prostate cancer.
Antonio H. Duarte, Sicilia Colli, Jorge L. Alves-Pereira, Max P. Martins, Francisco J. B. Sampaio, Cristiane F. Ramos   +5 more
doaj   +1 more source

Study of Immunohistochemical Marker Psma and Ki 67 Expression and Its Relation with Grading in Prostate Carcinoma

Annals of Urologic Oncology, 2022
Background Prostate cancer (PCa) is the second most frequent malignancy (after lung cancer) in men worldwide .In prostate cancer, immunohistochemistry (IHC) has an important role in the diagnostic confirmation.
Amit V Varma, Seema Jindal, Bela Sharda, Kamal Malukani, Shilpi Dosi, Pooja Kesharwani   +5 more
doaj   +1 more source

Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy

International Brazilian Journal of Urology, 2008
OBJECTIVE: There is evidence showing that Gleason grading of prostatic adenocarcinoma is one of the most powerful predictors of biological behavior and one of the most influential factors used to determine treatment for prostate cancer.
Marbele S. Guimaraes, Maisa M. Quintal, Luciana R. Meirelles, Luis A. Magna, Ubirajara Ferreira, Athanase Billis   +5 more
doaj   +1 more source

Nomograms Predict Survival Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A SEER-Based Study

Frontiers in Oncology, 2019
Background: Different proportions of Gleason pattern 3 and Gleason pattern 4 lead to various prognosis of prostate cancer with Gleason score 7. The objective of this study was to compare the survival outcomes of Gleason score 3+4 and 4+3 based on data ...
Xin Zhu, Xin Gou, Mi Zhou
doaj   +1 more source

Score de Gleason des biopsies prostatiques et celui des pièces de prostatectomies: Quelle corrélation?

African Journal of Urology, 2012
Le score de Gleason des biopsies prostatiques est primordial dans le traitement du cancer de la prostate. Il évalue l'agressivité et l’évolutivité de la tumeur.
A. Qarro, O. Ghoundale, K. Bazine, M. Asseban, M. Najoui, J. Samir, Y. Ouhbi, A. Beddouch, M. Lezrek, M. Alami   +9 more
doaj   +1 more source